TrialThe lancet. Diabetes & endocrinology2024

Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial.

Mikhail N Kosiborod et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.